MXCT – maxcyte, inc. (US:NASDAQ)
Stock Stats
News
MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025
With 66% institutional ownership, MaxCyte, Inc. (LON:MXCT) is a favorite amongst the big guns [Yahoo! Finance]
Down -30.2% in 4 Weeks, Here's Why MaxCyte (MXCT) Looks Ripe for a Turnaround [Yahoo! Finance]
MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market, Very Low Share Price [Seeking Alpha]
MaxCyte, Inc. (NASDAQ: MXCT) was given a new $6.00 price target on by analysts at BTIG Research. They now have a "buy" rating on the stock.
Form PRE 14A MAXCYTE, INC. For: Jun 18
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Soleymannezhad Ali
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Sandoval David I.
Form 4 MAXCYTE, INC. For: Mar 18 Filed by: Swirsky Douglas J
Form 4 MAXCYTE, INC. For: Mar 14 Filed by: Soleymannezhad Ali
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.